Rimonabant as potential treatment for the neglected epidemic of diabetes in the Middle East and Arabian Peninsula. Implication for prevention.
Ahmed
Mohamed H
MH
Department of Chemical Pathology, Southampton General Hospital, Southampton, United Kingdom. elziber@yahoo.com
D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators / Q000502:physiology; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D024821:Metabolic Syndrome / Q000188:drug therapy; D008877:Middle East / Q000453:epidemiology; D010880:Piperidines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000077285:Rimonabant; D012529:Saudi Arabia / Q000453:epidemiology
D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant